6-acetyl Morphine and Buprenorphine: New Useful Assays in the Opiate Crisis

Presented by

Dr. Mary Mayo

About this talk

The opiate crisis has reached epidemic proportions, evidenced by more than 17,000 deaths a year and $504 billion in economic costs in the U.S. alone¹. Healthcare providers and laboratories need highly specific tests that accurately detect drugs of abuse in patient-care, employment, athletic and prescription drug monitoring settings. In this webinar, Dr. Mary Mayo discusses two highly sensitive assays—the Syva® EMIT® II Plus 6-Acetylmorphine (6-AM) and Buprenorphine (BUP)—that expand available options for drugs-of-abuse testing. After attending this webinar, you will be able to describe the: • Differences in opioid drugs • Magnitude of the opioid epidemic • Reasons to use specific drug tests related to opioids • Performance characteristics of the Syva EMIT II Plus 6-AM and BUP assays P.A.C.E. credit is available for your participation.* Presenter: Mary Mayo, Ph.D. Dr. Mary Mayo is a medical affairs manager with Beckman Coulter Diagnostics, with more than 25 years’ experience in the clinical laboratory. This includes twelve years as a laboratory director, nine years as director of clinical chemistry at a tertiary-care academic hospital and three years as the laboratory director of a commercial laboratory. References: ¹ CDC. “Opioid Overdoses Treated in Emergency Departments.” https://www.cdc.gov/vitalsigns/opioid-overdoses/. Accessed 6 Mar 2018. *Beckman Coulter Inc. is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. These credits are recognized by the State of California. Most programs also provide State of Florida credits (with valid license number). At this time, we cannot issue continuing education credits for those who provide healthcare (or work for an institution that provides healthcare) in Massachusetts or Vermont.

Related topics:

More from this channel

Upcoming talks (0)
On-demand talks (70)
Subscribers (21760)
Beckman Coulter Diagnostics develops clinical diagnostic products that help advance and optimize the clinical laboratory. Beckman Coulter’s instruments, systems and tests help streamline processes to enhance efficiency, reduce costs and speed the delivery of results. For more than 75 years, Beckman Coulter has been a global leader devoted to providing solutions to laboratories of all sizes – offering a broad portfolio of chemistry, immunoassay, hematology, urinalysis, automation and information systems. Beckman Coulter is, and always has been, singularly devoted to moving science, innovation and the lab forward.